These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34888694)

  • 1. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021.
    Anders HJ; Loutan J; Bruchfeld A; Fernández-Juárez GM; Floege J; Goumenos D; Turkmen K; van Kooten C; Frangou E; Stevens KI; Kronbichler A; Segelmark M; Tesar V
    Nephrol Dial Transplant; 2023 Feb; 38(3):551-561. PubMed ID: 34888694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
    Bertsias GK; Tektonidou M; Amoura Z; Aringer M; Bajema I; Berden JH; Boletis J; Cervera R; Dörner T; Doria A; Ferrario F; Floege J; Houssiau FA; Ioannidis JP; Isenberg DA; Kallenberg CG; Lightstone L; Marks SD; Martini A; Moroni G; Neumann I; Praga M; Schneider M; Starra A; Tesar V; Vasconcelos C; van Vollenhoven RF; Zakharova H; Haubitz M; Gordon C; Jayne D; Boumpas DT;
    Ann Rheum Dis; 2012 Nov; 71(11):1771-82. PubMed ID: 22851469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
    Kostopoulou M; Fanouriakis A; Cheema K; Boletis J; Bertsias G; Jayne D; Boumpas DT
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32699043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus nephritis: new progress in diagnosis and treatment.
    Yu C; Li P; Dang X; Zhang X; Mao Y; Chen X
    J Autoimmun; 2022 Oct; 132():102871. PubMed ID: 35999111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Lupus Nephritis: Core Curriculum 2020.
    Parikh SV; Almaani S; Brodsky S; Rovin BH
    Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
    Groot N; de Graeff N; Marks SD; Brogan P; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Özen S; Pilkington CA; Ravelli A; Royen-Kerkhof AV; Uziel Y; Vastert BJ; Wulffraat NM; Beresford MW; Kamphuis S
    Ann Rheum Dis; 2017 Dec; 76(12):1965-1973. PubMed ID: 28877866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus nephritis].
    Mucke J; Schneider M
    Z Rheumatol; 2023 Feb; 82(1):40-52. PubMed ID: 36063165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
    De Rosa M; Azzato F; Toblli JE; De Rosa G; Fuentes F; Nagaraja HN; Nash R; Rovin BH
    Kidney Int; 2018 Oct; 94(4):788-794. PubMed ID: 30045812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
    Jin SY; Huang DL; Dang XQ; Yi ZW
    Paediatr Int Child Health; 2017 Nov; 37(4):286-291. PubMed ID: 28463080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT; Hussen SU; Getachew S; Berha AB
    BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis.
    Fava A; Fenaroli P; Rosenberg A; Bagnasco S; Li J; Monroy-Trujillo J; Fine D; Atta MG; Petri M
    Rheumatology (Oxford); 2022 May; 61(6):2483-2493. PubMed ID: 34664621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Boneparth A; Wenderfer SE; Moorthy LN; Radhakrishna SM; Sagcal-Gironella AC; von Scheven E;
    Lupus; 2017 Mar; 26(3):299-306. PubMed ID: 27510603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class IV lupus nephritis.
    Xu S; Liu Z; Chen H; Zeng C; Zhang H; Liu Z; Hu W
    Clin Nephrol; 2014 Jun; 81(6):411-8. PubMed ID: 25017669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
    Ahn SS; Yoo J; Lee SW; Song JJ; Park YB; Jung SM
    Lupus; 2022 Apr; 31(5):588-595. PubMed ID: 35316102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.
    Pereira M; Muscal E; Eldin K; Hicks MJ; Sagcal-Gironella ACP; DeGuzman M; Wenderfer SE
    Pediatr Nephrol; 2017 Dec; 32(12):2283-2291. PubMed ID: 28717937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.